| Nordhof, Eckard |
n. a. |
Scienion (Group) |
Germany |
| Nordmann, Carsten (Biomol GmbH 201108 Managing Director) |
Managing Director |
Biomol GmbH (DE) |
Germany |
| Norstedt, Irene (IMI 201502 Acting Executive Director) |
President/Director/Head Business Group/Unit/Division |
Innovative Medicines Initiative (IMI) |
EU (European Union) |
| Norström, Erik (Tecan 201712c– Head of Corporate Development before Chr Hansen + Nobel Biocare + Roche) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
| Northoff, Stefan (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
| Nota, Pieter (Philips –201707 Chief Buiness leader Personal Health business + Chief Marketing Officer LEFT 7/17) |
Chief Business Officer (CBO) |
Philips (Group) |
Netherlands |
| Nottrott, Stephanie (Isenbruck Bösl Hörschler 201511 Patent Attorney) |
Patent Attorney |
Isenbruck | Bösl | Hörschler LLP |
Germany |
| Novak, Filip (Qiagen Hamburg 200608 Manager Regulatory Compliance) |
Regulatory Affairs Manager |
Qiagen (Group) |
Germany |
| Novak, Lidia (Biognosys 2019089 CFO) |
Chief Financial Officer (CFO) |
Biognosys AG |
Switzerland |
| Novak, Rodger (CRISPR Therapeutics 201712– Board Chairman 2013–201711 CEO + Co-Founder before Sanofi + Nabriva GmbH) |
Board member, non-executive |
CRISPR Therapeutics (Group) |
Switzerland |
| Novo, David (De Novo Software 201111 President) |
President/Director/Head Business Group/Unit/Division |
De Novo Software (US) |
United States (USA) |
| Novorol, Claire (Ada Health 201712 CMO + Co-Founder) |
Chief Medical Officer (CMO) |
Ada Health (Group) |
Germany |
| Nowack, Björn (SensID GmbH 201905 Managing Director (CEO) + Co-Founder) |
Chief Executive Officer (CEO) |
SensID GmbH |
Germany |
| Nowak, Michael J. (Yorkville 201108 Managing Director of Yorkville Advisors LLC) |
Managing Director |
Yorkville Group (Group) |
United States (USA) |
| Noyes, Catherine (GeneBio 201008 Marketing Manager) |
Sales Manager / Marketing Manager |
GeneBio (Group) |
Switzerland |
| Nuechterlein, Carole (Roche 201604 Head of Roche Venture Fund) |
Investment Manager |
Roche (Group) |
Switzerland |
| Nugent, Kerry (Michrom 201008 President + founder) |
President/Director/Head Business Group/Unit/Division |
Bruker Corporation (Group) |
United States (USA) |
| Nukal, Balaji (SeedWorks India 201506 Managing Director) |
Managing Director |
Bayer (Group) |
India |
| Nunn, Simon (Thermo Fisher 201308 Global Marketing Director Molecular Spectroscopy) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
United States (USA) |
| Nussbaumer, Peter (Max Planck 201104 Managing Director of Lead Discovery Center GmbH) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Nutzhorn, Christa (Cytocentrics 200809 CEO) |
Chief Executive Officer (CEO) |
Cytocentrics (Group) |
Germany |
| Nuwaysar, Emile (Bayer 201904 CEO of BlueRock Therapeutics) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Canada |
| Nygaard, Geert Walther (Epigenomics 200702–201209 CEO LEFT 9/12 before Abbott GmbH + Dako + Beckman) |
Chief Executive Officer (CEO) |
Epigenomics (Group) |
Germany |
| Nürnberger, Christian (TO DO Life Sciences 201108 Managing Director) |
Managing Director |
TO DO Life Sciences (Group) |
Germany |
| Nüsslein-Vollhard, Christiane |
n. a. |
Taconic (Group) |
Germany |
| Nystroem, Katarina (GATC 200803– Sales Manager Stockholm) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Nüßlein, Bernd (nadicom 200503 General Manager + founder) |
General Manager (management) |
Nadicom – Gesellschaft für angewandte Mikrobiologie mbH |
Germany |
| Näder, Hans Georg (Ottobock 201706 President + major shareholder + grandson of Otto Bock) |
Managing Director |
Ottobock (Otto Bock) (Group) |
Germany |
| Nörenberg, Astrid (Upcyte Technologies GmbH 201507– Managing Director + Founder) |
Managing Director |
Upcyte Technologies GmbH |
Germany |
| Nöthen, Markus (Life & Brain 201912 Managing Director) |
Managing Director |
Life & Brain GmbH |
Germany |
| Nößner, Elfriede (Helmholtz 201901 Professor + Head of Immunoanalytics at Helmholtz-Zentrum München) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| O'Day, Daniel (Gilead 201903 CEO before Roche Pharma CEO + COO + Roche Diagnostics COO joined Roche 1987) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| Oakley, Andrew J. (Autolus 201806– CFO before Sosei + Vectura + Novimmune + Actelion) |
Chief Financial Officer (CFO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Obama, Barack (United States (govt) 2008 President) |
Governmental Officer (personnel) |
United States (govt) |
United States (USA) |
| Obbad, Kamal (Nebula Genomis 201808 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nebula Genomics (US) |
United States (USA) |
| Ober, Mario (IBFB Pharma 200502 Investment Director + Chairman Supervisory Board) |
Investment Manager |
Medicines Company (Group) |
Germany |
| Oberacher, Herbert (Medical Univ Innsbruck 201110 Assistant Prof at Institute of Legal Medicine) |
Assistant Professor / Associate Professor |
Medical University Innsbruck (MUI) |
Austria |
| Oberheitmann, Boris (Q-Bioanalytic Managing Director + co-founder + Sequid 2007–201007 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
| Oberholz, Alfred (VCI 200808 chairman) |
n. a. |
VCI (Verband der Chemischen Industrie e. V.) |
Germany |
| Oberländer, Monique (CCS Cell Culture Service 201105) |
n. a. |
Evotec (Group) |
Germany |
| Oberländer, Uwe (Roche Diagnostics GmbH 200703 Leiter Marketing Labordiagnostik) |
n. a. |
Roche (Group) |
Germany |
| Obermayr, Franz (Panoptes Pharma GmbH 201309 CEO) |
Chief Executive Officer (CEO) |
Panoptes Pharma GmbH |
Austria |
| Obitzhofer, Karoline (Biocrates 200805 Marketing Manager LEFT before 10/11) |
Sales Manager / Marketing Manager |
Biocrates (Group) |
Austria |
| Obrecht, Daniel (Polyphor 201107 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Polyphor Ltd. (SIX: POLN) |
Switzerland |
| Obrecht, Jean-Pierre (Polyphor 201504 Non-executive Board Director before CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Polyphor Ltd. (SIX: POLN) |
Switzerland |
| Ochel, Martina (Sanofi 201203 Managing Director at Genzyme GmbH) |
Managing Director |
Sanofi (Group) [since May 2011] |
Germany |
| Odgaard, Katie (Zyme Communications 201108 Senior Account Manager before College Hill Life Sciences) |
Public Relations Manager / Investor Relations Manager |
Zyme Communications Ltd. |
United Kingdom (GB) |
| Odlander, Björn (HealthCap 200406 Managing Director + Jerini Board Member) |
Managing Director |
Odlander Fredrikson (Group) |
Sweden |
| Oehl, Heinz (AstraZeneca 201707– VP Global Marketing + Corp Business Development at Definiens) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
Germany |
| Oehler, Martin (Capical GmbH 201109 Managing Director + co-founder) |
Managing Director |
Capical GmbH |
Germany |
| Oehlers, Dirk (Lonza 201610 Head Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Lonza Group (Group) |
Switzerland |
| Oehlmann, Ralph (IMGM Laboratories 200808 Director BusDev) |
Business Development Manager / Strategy Manager |
IMGM Laboratories GmbH |
Germany |
| Oehlschläger, Wilhelm (Bayer 201206– Managing Director Bayer Business Services GmbH) |
Managing Director |
Bayer (Group) |
Germany |
| Oelkers, Guido (Swedish Orphan Biovitrum 201705– CEo before BSN Medical GmbH + Nycomed) |
Chief Executive Officer (CEO) |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Oelmüller, Uwe (Qiagen 200905 Senior Director R&D Diagnostic Sample Preparation and Stabilization) |
Research & Development Manager |
Qiagen (Group) |
Germany |
| Oelrich, Stefan (Bayer 201811– Head of Pharma division before Sanofi Head of Diabetes + Cardiovascular) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Oesch, Bruno (Neurotune 200903– CEO before co-founder + Board Chairman) |
Chief Executive Officer (CEO) |
Neurotune AG |
Switzerland |
| Oetker, Roland (ROI Verwaltungsgesellschaft mbH 200108 Managing Director + Founder) |
Managing Director |
ROI Verwaltungsgesellschaft mbH |
Germany |
| Offerhaus, Mark (Micreos 201602 CEO) |
Chief Executive Officer (CEO) |
Micreos (Group) |
Netherlands |
| Ogunshola, Lara (Lipidon 201808 Chief Marketing Officer) |
Sales Manager / Marketing Manager |
Lipidon AG (Lipidon Analytics) |
Switzerland |
| Oh, Daesuk (Miltenyi Biotec 201306– General Manager of Miltenyi Biotec Korea) |
General Manager (management) |
Miltenyi Biotec (Group) |
Korea, Republic of |
| Ohtani, Masahiko (Evotec 201307– VP Business Development Japan) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Ohtsuki, Atsushi (Nanion 201501 General Manager Nanion Japan) |
General Manager (management) |
Nanion Technologies Research Lab Tokyo (at TWIns) |
Japan |
| Okrongly, David (Opko Health 201307– President Diagnostics unit before Quanterix + Siemens Healthcare) |
Chief Executive Officer (CEO) |
Opko Health (Group) |
United States (USA) |
| Oldekor, Herr |
n. a. |
Deutsche Bank (Group) |
Germany |
| Olek, Alexander (Epigenomics 200508) |
n. a. |
Epigenomics (Group) |
Germany |
| Olek, Sven (Epiontis 2003– Co-Founder) |
Managing Director |
Precision Medicine Group (Group) |
Germany |
| Olgemöller, Bernhard (Labor Becker Olgemöller 200909 Head) |
President/Director/Head Business Group/Unit/Division |
Labor Becker, Olgemöller & Kollegen |
Germany |
| Oliveto, Joseph (Milestone Pharmaceuticals 201703– CEO before Chelsea Therapeutics + Galleon + Pappas Ventures) |
Chief Executive Officer (CEO) |
Milestone Pharmaceuticals (Group) |
Canada |
| Ollier, Michèle (Medixci Ventures 201602– General Parnter before Index Ventures + Funxional Therapeutics) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
| Olmes, Andreas (High-Tech Gründerfonds 200901 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Olschewski, Torsten (Analytik Jena 200811 VP Sales + Service + Marketing) |
Sales Manager / Marketing Manager |
Endress+Hauser (Group) |
Germany |
| Olsen, Jesper Velgaard (Univ Copenhagen 201404– Professor + Vice Director of NNF-CPR joined 5/09 before MPI) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Omari, Abdelghani (Paion 201409– CFO joined 200810 as VP Finance before KPMG Cologne) |
Chief Financial Officer (CFO) |
Paion (Group) |
Germany |
| Onakunle, Yemi (Selexis 201606 VP Licensing + Business Development) |
Business Development Manager / Strategy Manager |
JSR Corporation (Group) |
Switzerland |
| Ong, Siew Hwa (Acumen Research Laboratories 201510 CEO + Adjunct Prof at NUS) |
Chief Executive Officer (CEO) |
Acumen Research Laboratories Pte Ltd. |
Singapore |
| Onsi, Douglas E. (HealthCare Ventures 201601 Managing Director + Tensha Therapeutics 201601 CEO) |
Managing Director |
HealthCare Ventures (Group) |
United States (USA) |
| Onuscheck, Michael (Novartis 201810 President Global Business + Innovation at Alcon) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Switzerland |
| Opella, Stanley (Univ California 201312 Prof of Chemistry + Biochemistry at UCSD) |
Professor |
University of California (System) |
United States (USA) |
| Oppitz, Norbert (Swedish Orphan Biovitrum 201710– SVP Specialty Care before BSN Medical + Endo + Takeda/Nycomed + Roche) |
President/Director/Head Business Group/Unit/Division |
Swedish Orphan Biovitrum (Sobi) (Group) |
Sweden |
| Opstelten, Ron (Greiner 201511 Managing Director at Greiner Bio-One Diagnostics GmbH before Operon Biotechnologies GmbH) |
Managing Director |
Greiner (Group) |
Austria |
| Oredsson, Michael (BioInvent 201310 CEO before CEO at Probi AB before Pharmacia) |
Chief Executive Officer (CEO) |
BioInvent International AB (OMXS: BINV) |
Sweden |
| Oren, Dan (Dexcel 1068– CEO + Founder) |
Chief Executive Officer (CEO) |
Dexcel Pharma (Group) |
Israel |
| Orloff, John (Alexion 2010706– EVP Head RnD before Novelion + Baxalta + Baxter + Merck Serono) |
Research & Development Manager |
Alexion (Group) |
United States (USA) |
| Orlowski, Jochen (MorphoSys 201512– Corp Communications + IR Relations before 4SC AG + Süd-Chemie) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Orlowski, Marek (Joint Polish Investment Fund 201503 General Partner before Co-founder of Nepentes SA) |
General Partner (venture partner) |
Joint Polish Investment Fund (JPIF) (Group) |
Netherlands |
| Ornell, John (Bruker 201508– Board Director before Waters 2001–2013 CFO RETIRED 2014) |
Board member, non-executive |
Bruker Corporation (Group) |
United States (USA) |
| Oroszlan, Peter (Zeptosens 200404 Director Business Development) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Switzerland |
| Orpin, Tristan (Illumina 201406 SVP + General Manager Reproductive + Genetic Health before SVP Commercial Operations) |
Sales Manager / Marketing Manager |
Illumina (Group) |
United States (USA) |
| Orquera, Christian |
n. a. |
Bankgesellschaft Berlin (Group) |
Germany |
| Orth, Gisela (Qiagen 200902– VP Global Human Resources before Continental) |
Human Resources Manager |
Qiagen (Group) |
Germany |
| Orwin, John (Atreca 201901 CEO before Genentech + Tibotec) |
Chief Executive Officer (CEO) |
Atreca Inc. (Nasdaq: BCEL) |
United States (USA) |
| Osborne, Lisa (Rana Healthcare Solutions LLC 201311 CEO + Founder before Waggener Edstrom Worldwide) |
Public Relations Manager / Investor Relations Manager |
Rana Healthcare Solutions LLC |
United States (USA) |
| Oschmann, Stefan (Merck (DE) 201604– CEO before Executive Board Member since 2011 before MSD) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Ossmann, Christian (MKS Instruments 2012– Sales Manager Continental Europe) |
Sales Manager / Marketing Manager |
MKS Instruments (Group) |
Germany |
| Oster, Wolfgang |
n. a. |
PolyTechnos Funds |
Germany |
| Ostermeier, Max G. (Implandata Ophtalmic Products GmbH 201201 Managing Director + Co-founder) |
Managing Director |
Implandata Ophthalmic Products GmbH (IOP) |
Germany |
| Osterwald, Hermann (NextPharma 201010 Managing Director NextPharma GmbH) |
Managing Director |
NextPharma (Group) |
Germany |
| Osterwalder, Bruno (Roche + Merck Serono) |
n. a. |
Roche (Group) |
Switzerland |
| Osthus, Torsten (Osthus 201508 Managing Director + Founder) |
Sales Manager / Marketing Manager |
Osthus (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
1 2 3 ... 43 44 45 ... 68 69 70 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
